Your browser doesn't support javascript.
loading
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Elsawy, Mahmoud; Chavez, Julio C; Avivi, Irit; Larouche, Jean-François; Wannesson, Luciano; Cwynarski, Kate; Osman, Keren; Davison, Kelly; Rudzki, Jakob D; Dahiya, Saurabh; Dorritie, Kathleen; Jaglowski, Samantha; Radford, John; Morschhauser, Franck; Cunningham, David; Martin Garcia-Sancho, Alejandro; Tzachanis, Dimitrios; Ulrickson, Matthew L; Karmali, Reem; Kekre, Natasha; Thieblemont, Catherine; Enblad, Gunilla; Dreger, Peter; Malladi, Ram; Joshi, Namita; Wang, Wei-Jhih; Solem, Caitlyn T; Snider, Julia Thornton; Cheng, Paul; To, Christina; Kersten, Marie José.
  • Elsawy M; Queen Elizabeth II Health Sciences Centre and Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
  • Chavez JC; Moffitt Cancer Center, Tampa, FL.
  • Avivi I; Hematology Institute, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Larouche JF; Centre Hospitalier Universitaire (CHU) de Québec, Hôpital de l'Enfant-Jésus, Québec, QC, Canada.
  • Wannesson L; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.
  • Cwynarski K; Department of Haematology, University College London Hospitals National Health Services (NHS) Foundation Trust, London, United Kingdom.
  • Osman K; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Davison K; Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada.
  • Rudzki JD; Department of Hematology & Oncology, The Medical University of Innsbruck, University Clinic for Internal Medicine, Innsbruck, Austria.
  • Dahiya S; Greenebaum Comprehensive Cancer Center, Transplant and Cellular Therapy Program, University of Maryland Medical Center, Baltimore, MD.
  • Dorritie K; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA.
  • Jaglowski S; Comprehensive Cancer Center, Blood and Marrow Transplant Program, The Ohio State University, Columbus, OH.
  • Radford J; Division of Cancer Sciences, The Christie NHS Foundation Trust and the University of Manchester, Manchester, United Kingdom.
  • Morschhauser F; Groupe de Recherche sur les formes Injectables et les Technologies Associées, University of Lille, CHU Lille, Lille, France.
  • Cunningham D; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Martin Garcia-Sancho A; Hematology Department, Salamanca University Hospital, Institute of Biomedical Research of Salamanca (IBSAL), Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Salamanca, Spain.
  • Tzachanis D; Moores Cancer Center, University of California, San Diego, La Jolla, CA.
  • Ulrickson ML; Banner MD Anderson Cancer Center, Gilbert, AZ.
  • Karmali R; Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.
  • Kekre N; The Ottawa Hospital, Ottawa, ON, Canada.
  • Thieblemont C; University of Paris, Hôpital Saint-Louis, Hemato-Oncology, DMU DHI, Paris, France.
  • Enblad G; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Dreger P; Department of Medicine, University of Heidelberg, Heidelberg, Germany.
  • Malladi R; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Joshi N; University Hospitals Birmingham NHS Foundation Trust, Cambridge, United Kingdom.
  • Wang WJ; OPEN Health, Bethesda, MD.
  • Solem CT; OPEN Health, Bethesda, MD.
  • Snider JT; OPEN Health, Bethesda, MD.
  • Cheng P; Kite, a Gilead Company, Santa Monica, CA.
  • To C; Kite, a Gilead Company, Santa Monica, CA.
  • Kersten MJ; Kite, a Gilead Company, Santa Monica, CA.
Blood ; 140(21): 2248-2260, 2022 11 24.
Article en En | MEDLINE | ID: mdl-35839452
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article